TSLA | ||
---|---|---|
OUTLOOK RATING 1..100 | 23 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 98 Overvalued | |
PROFIT vs RISK RATING 1..100 | 44 | |
SMR RATING 1..100 | 77 | |
PRICE GROWTH RATING 1..100 | 3 | |
P/E GROWTH RATING 1..100 | 4 | |
SEASONALITY SCORE 1..100 | 75 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
ETV | TSLA | |
---|---|---|
RSI ODDS (%) | 2 days ago75% | 2 days ago76% |
Stochastic ODDS (%) | 2 days ago69% | 2 days ago75% |
Momentum ODDS (%) | 2 days ago79% | 2 days ago78% |
MACD ODDS (%) | 2 days ago85% | 2 days ago69% |
TrendWeek ODDS (%) | 2 days ago83% | 2 days ago78% |
TrendMonth ODDS (%) | 2 days ago82% | 2 days ago79% |
Advances ODDS (%) | 9 days ago84% | 8 days ago83% |
Declines ODDS (%) | 3 days ago72% | 6 days ago77% |
BollingerBands ODDS (%) | N/A | 2 days ago78% |
Aroon ODDS (%) | 2 days ago77% | 2 days ago84% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
PIEJX | 33.73 | N/A | N/A |
Principal Glb Emerging Markets J | |||
ETAHX | 40.98 | N/A | N/A |
Eventide Healthcare & Life Sciences A | |||
MGTCX | 9.30 | N/A | N/A |
Transamerica Mid Cap Growth C | |||
LICSX | 18.22 | N/A | N/A |
Lord Abbett International Equity R4 | |||
RGAEX | 87.46 | -0.57 | -0.65% |
American Funds Growth Fund of Amer R4 |
A.I.dvisor tells us that ETV and TSLA have been poorly correlated (+21% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ETV and TSLA's prices will move in lockstep.
Ticker / NAME | Correlation To ETV | 1D Price Change % | ||
---|---|---|---|---|
ETV | 100% | +0.14% | ||
TSLA - ETV | 21% Poorly correlated | -4.45% | ||
AAPL - ETV | 8% Poorly correlated | -0.08% | ||
MSFT - ETV | 7% Poorly correlated | -0.87% | ||
META - ETV | 3% Poorly correlated | -0.36% | ||
NVDA - ETV | -1% Poorly correlated | -0.27% | ||
More |